These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 134751

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A method using fibrin-fixed Blue Dextran for determining the plasmin and plasmin inhibitor activities in human plasma.
    Tamura Y, Otsuka A, Sone K, Sakurai E, Mori H, Sumi H, Kosugi T, Fujii S.
    Biochim Biophys Acta; 1978 Jul 07; 525(1):194-9. PubMed ID: 150858
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effects of heparin and epsilon-aminocaproic acid in dogs on plasmin-125-I generation in response to urokinase injections and venous injury.
    Takeda Y, Parkhill TR, Nakabayashi M.
    J Clin Invest; 1972 Oct 07; 51(10):2678-85. PubMed ID: 4262519
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator.
    Kaplan AP, Goetzl EJ, Austen KF.
    J Clin Invest; 1973 Oct 07; 52(10):2591-5. PubMed ID: 4729052
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.
    Husain SS.
    Biochemistry; 1991 Jun 11; 30(23):5797-805. PubMed ID: 1828371
    [Abstract] [Full Text] [Related]

  • 36. Plasma fibronectin enhances fibrinolytic system in vitro.
    Gilboa N, Kaplan JE.
    Thromb Haemost; 1985 Oct 30; 54(3):639-44. PubMed ID: 2935966
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation.
    Kaplan AP, Meier HL, Mandle R.
    Semin Thromb Hemost; 1976 Jul 30; 3(1):1-26. PubMed ID: 139682
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients.
    Levi M, Hack CE, de Boer JP, Brandjes DP, Büller HR, ten Cate JW.
    Agents Actions Suppl; 1992 Jul 30; 38 ( Pt 2)():292-8. PubMed ID: 1462834
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.